Great-West Lifeco (TSE:GWO) PT Raised to C$45.00

Great-West Lifeco (TSE:GWO) had its price target increased by BMO Capital Markets from C$44.00 to C$45.00 in a research note issued on Friday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ price target suggests a potential upside of 6.56% from the company’s previous close.

Several other research firms also recently weighed in on GWO. Scotiabank raised their target price on Great-West Lifeco from C$42.00 to C$44.00 and gave the company a “sector perform” rating in a research report on Tuesday, February 6th. National Bankshares raised their target price on Great-West Lifeco from C$42.00 to C$43.00 and gave the company a “sector perform” rating in a research report on Thursday. Royal Bank of Canada raised their target price on Great-West Lifeco from C$44.00 to C$45.00 and gave the company a “sector perform” rating in a research report on Friday. CIBC lifted their price objective on Great-West Lifeco from C$44.00 to C$46.00 and gave the stock a “neutral” rating in a research report on Friday, February 16th. Finally, TD Securities reduced their price objective on Great-West Lifeco from C$45.00 to C$44.00 in a research report on Thursday. Six research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Great-West Lifeco currently has an average rating of “Hold” and a consensus price target of C$43.60.

Great-West Lifeco Stock Up 1.2 %

Great-West Lifeco stock opened at C$42.23 on Friday. The firm has a market cap of C$39.38 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 2.26 and a beta of 0.86. Great-West Lifeco has a 52 week low of C$37.06 and a 52 week high of C$45.18. The business’s 50-day moving average price is C$41.95 and its 200 day moving average price is C$42.23. The company has a quick ratio of 22.18, a current ratio of 12.42 and a debt-to-equity ratio of 32.33.

Great-West Lifeco (TSE:GWO) last posted its earnings results on Wednesday, February 14th. The company reported C$1.04 EPS for the quarter, topping the consensus estimate of C$0.99 by C$0.05. Great-West Lifeco had a return on equity of 10.28% and a net margin of 7.95%. The firm had revenue of C$20.21 billion for the quarter. As a group, sell-side analysts anticipate that Great-West Lifeco will post 4.137561 earnings per share for the current year.

Insiders Place Their Bets

In other Great-West Lifeco news, Senior Officer Bradley John Fedorchuk sold 2,900 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of C$42.44, for a total transaction of C$123,062.08. In other Great-West Lifeco news, Senior Officer Bradley John Fedorchuk sold 2,900 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of C$42.44, for a total transaction of C$123,062.08. Also, Senior Officer Dervla Mary Tomlin sold 5,400 shares of the firm’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of C$42.33, for a total value of C$228,590.10. Insiders sold a total of 13,300 shares of company stock valued at $566,402 over the last quarter. 70.57% of the stock is owned by insiders.

Great-West Lifeco Company Profile

Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.